DrugPatentWatch Database Preview
VERSACLOZ Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Versacloz, and what generic alternatives are available?
Versacloz is a drug marketed by Tasman Pharma and is included in one NDA.
The generic ingredient in VERSACLOZ is clozapine. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the clozapine profile page.
Summary for VERSACLOZ
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 92 |
| Patent Applications: | 4,299 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | VERSACLOZ at DailyMed |
Pharmacology for VERSACLOZ
| Drug Class | Atypical Antipsychotic |
Medical Subject Heading (MeSH) Categories for VERSACLOZ
Synonyms for VERSACLOZ
| 1333667-72-3 |
| 3-chloro-6-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine |
| 3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine |
| 3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine |
| 3-Hydroxy-2-phenyl-propionic acid 8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl ester |
| 5786-21-0 |
| 5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)- |
| 5H-Dibenzo[b,e][1,4]diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)- |
| 6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1,3(8),4,6,10,12,14-heptaene |
| 6-CHLORO-10-(4-METHYLPIPERAZIN-1-YL)-2,9-DIAZATRICYCLO[9.4.0.0(3),?]PENTADECA-1,3(8),4,6,10,12,14-HEPTAENE |
| 6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0(3),]pentadeca-1,3,5,7,10,12,14-heptaene |
| 6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,9,12,14-heptaene |
| 786C210 |
| 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e)(1,4)diazepine |
| 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine |
| 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine |
| 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine |
| 8-chloro-11-(4-methyl-piperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine |
| 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine |
| 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine (Clozapine) |
| 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine( Clozepine ) |
| 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine(Ciozapine) |
| 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine(Clopazine) |
| 8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine |
| 8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine |
| 8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine |
| 8-Chloro-11-(4-methylpiperazino)-5H-dibenzo[b,e][1,4]diazepine |
| AB00052158_15 |
| AB00052158_16 |
| AB00052158-13 |
| AB00052158-14 |
| AB0013069 |
| AB1009321 |
| AC1L1EJE |
| AC1Q3OPZ |
| AC1Q3ZWP |
| AKOS005064444 |
| AKOS026749900 |
| AN-16004 |
| ANW-42470 |
| AOB5635 |
| Asaleptin |
| Azaleptin |
| Azaleptine |
| BC204168 |
| BDBM22869 |
| BDBM50001884 |
| BG0154 |
| Bio1_000436 |
| Bio1_000925 |
| Bio1_001414 |
| Bio2_000310 |
| Bio2_000790 |
| BRD-K37289225-001-09-1 |
| BRN 0764984 |
| C 6305 |
| C-36335 |
| C06924 |
| C18H19ClN4 |
| CAS-5786-21-0 |
| CC0176 |
| CCG-39881 |
| CCRIS 9171 |
| CHEBI:3766 |
| CHEBI:92657 |
| CHEMBL42 |
| Clopine (TN) |
| Clorazil |
| Clozapin |
| Clozapina |
| Clozapina [INN-Spanish] |
| clozapine |
| Clozapine (Clozaril) |
| Clozapine (JAN/USP/INN) |
| Clozapine [USAN:INN:BAN] |
| Clozapine [USAN:USP:INN:BAN] |
| Clozapine 1.0 mg/ml in Acetonitrile |
| Clozapine for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Clozapine Resolution Mixture, United States Pharmacopeia (USP) Reference Standard |
| CLOZAPINE, 8-CHLORO-11-(4-METHYL-PIPERAZIN-1-YL)-5H-DIBENZO[B,E][1,4]DIAZEPINE |
| Clozapine, British Pharmacopoeia (BP) Reference Standard |
| Clozapine, drug standard, 1.0 mg/mL in methanol |
| Clozapine, European Pharmacopoeia (EP) Reference Standard |
| Clozapine, solid |
| Clozapine, United States Pharmacopeia (USP) Reference Standard |
| clozapine(tautomer) |
| Clozapinum |
| Clozapinum [INN-Latin] |
| CLOZARIL |
| Clozaril (TN) |
| CPD000058365 |
| CS-0644 |
| CTK6I2968 |
| D-107 |
| D00283 |
| D0Z1RV |
| DB00363 |
| Denzapine (TN) |
| DivK1c_000343 |
| DSSTox_CID_2855 |
| DSSTox_GSID_22855 |
| DSSTox_RID_76759 |
| DTXSID5022855 |
| EINECS 227-313-7 |
| EN300-52510 |
| EU-0100276 |
| Fazaclo |
| Fazaclo (TN) |
| Fazaclo ODT |
| Froidir (TN) |
| FT-0082373 |
| FT-0600382 |
| GP7633 |
| GTPL38 |
| H482 |
| HF 1854 |
| HF-1854 |
| HF1854 |
| HMS1361P12 |
| HMS1569E21 |
| HMS1791P12 |
| HMS1921C16 |
| HMS1989P12 |
| HMS2089L13 |
| HMS2092I16 |
| HMS2096E21 |
| HMS2235E19 |
| HMS3259J17 |
| HMS3260H14 |
| HMS3266A10 |
| HMS3371H05 |
| HMS3402P12 |
| HMS3657E15 |
| HMS501B05 |
| HSDB 6478 |
| HY-14539 |
| I06-0047 |
| Iprox |
| J60AR2IKIC |
| KBio1_000343 |
| KBio2_000310 |
| KBio2_000599 |
| KBio2_002878 |
| KBio2_003167 |
| KBio2_005446 |
| KBio2_005735 |
| KBio3_000619 |
| KBio3_000620 |
| KBio3_002979 |
| KBioGR_000310 |
| KBioGR_001336 |
| KBioSS_000310 |
| KBioSS_000599 |
| Klozapol |
| Klozapol (TN) |
| KS-1166 |
| L000195 |
| L013417 |
| Leponex |
| Leponex (TN) |
| Lepotex |
| LEX-123 |
| Lopac-C-6305 |
| LP00276 |
| LS-60881 |
| LX 100-129 |
| MCULE-3665900006 |
| MFCD00153785 |
| MLS000028472 |
| MLS001077282 |
| MolPort-001-728-041 |
| MolPort-006-167-528 |
| NC00667 |
| NCGC00015254-01 |
| NCGC00015254-02 |
| NCGC00015254-03 |
| NCGC00015254-04 |
| NCGC00015254-05 |
| NCGC00015254-06 |
| NCGC00015254-07 |
| NCGC00015254-08 |
| NCGC00015254-09 |
| NCGC00015254-10 |
| NCGC00015254-11 |
| NCGC00015254-12 |
| NCGC00015254-13 |
| NCGC00015254-14 |
| NCGC00015254-15 |
| NCGC00015254-16 |
| NCGC00015254-17 |
| NCGC00015254-18 |
| NCGC00015254-20 |
| NCGC00022902-02 |
| NCGC00022902-04 |
| NCGC00022902-05 |
| NCGC00022902-06 |
| NCGC00022902-07 |
| NCGC00022902-08 |
| NCGC00022902-09 |
| NCGC00022902-10 |
| NCGC00022902-11 |
| NCGC00022902-12 |
| NCGC00022902-13 |
| NCGC00188978-01 |
| NCGC00260961-01 |
| NINDS_000343 |
| NSC-757429 |
| NSC757429 |
| Opera_ID_482 |
| Pharmakon1600-01500685 |
| PL001733 |
| Prestwick_693 |
| Prestwick0_000350 |
| Prestwick1_000350 |
| QZUDBNBUXVUHMW-UHFFFAOYSA-N |
| REGID_for_CID_2818 |
| s2459 |
| SAM002548976 |
| SAM002589962 |
| SBI-0050264.P004 |
| SC-12183 |
| SC-26976 |
| SCHEMBL33323 |
| SCHEMBL8397 |
| SMR000058365 |
| SPBio_000798 |
| SPBio_002340 |
| Spectrum_000139 |
| SPECTRUM1500685 |
| Spectrum2_000919 |
| Spectrum3_001828 |
| Spectrum4_000898 |
| SR-01000000096 |
| SR-01000000096-2 |
| TC-063560 |
| Tocris-0444 |
| Tox21_110113 |
| Tox21_110113_1 |
| Tox21_500276 |
| UNII-J60AR2IKIC |
| W-105432 |
| W-2845 |
| W-801 |
| Z1245633277 |
| Zaponex (TN) |
| ZINC19796155 |
| ZINC3872123 |
US Patents and Regulatory Information for VERSACLOZ
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tasman Pharma | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
